Collan Y - Search Results

1

Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M. Buhmeida A, et al. Among authors: collan y. Anticancer Res. 2011 Jan;31(1):97-103. Anticancer Res. 2011. PMID: 21273586

2

Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M. Buhmeida A, et al. Among authors: collan y. Anticancer Res. 2010 Jun;30(6):2185-91. Anticancer Res. 2010. PMID: 20651368

3

Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.

Abdalla F, Boder J, Markus R, Hashmi H, Buhmeida A, Collan Y. Abdalla F, et al. Among authors: collan y. Anticancer Res. 2009 May;29(5):1771-6. Anticancer Res. 2009. PMID: 19443402 Free article.

4

Estrogen receptor, progesterone receptor, and nuclear size features in female breast cancer in Libya: correlation with clinical features and survival.

Abdalla FB, Markus R, Buhmeida A, Boder J, Syrjänen K, Collan Y. Abdalla FB, et al. Among authors: collan y. Anticancer Res. 2012 Aug;32(8):3485-93. Anticancer Res. 2012. PMID: 22843935

5

Nuclear area is a prognostic determinant in advanced colorectal cancer.

Buhmeida A, Ristamäki R, Lamlum H, Bendardaf R, Heikkilä S, Collan Y, Syrjänen K, Pyrhönen S. Buhmeida A, et al. Among authors: collan y. Anticancer Res. 2005 Jul-Aug;25(4):3083-8. Anticancer Res. 2005. PMID: 16080569 Free article.

6

Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.

Buhmeida A, Algars A, Ristamäki R, Collan Y, Syrjänen K, Pyrhönen S. Buhmeida A, et al. Among authors: collan y. Anticancer Res. 2006 Jan-Feb;26(1B):455-62. Anticancer Res. 2006. PMID: 16739305 Free article.

7

Nuclear morphometry in FNABs of breast disease in Libyans.

Abdalla F, Boder J, Buhmeida A, Hashmi H, Elzagheid A, Collan Y. Abdalla F, et al. Among authors: collan y. Anticancer Res. 2008 Nov-Dec;28(6B):3985-9. Anticancer Res. 2008. PMID: 19192660 Free article.

8

Image DNA cytometry in FNABs of Libyan breast disease.

Abdalla FB, Boder JM, Buhmeida A, Elzagheid AI, Collan Y. Abdalla FB, et al. Among authors: collan y. Anticancer Res. 2010 Jan;30(1):175-81. Anticancer Res. 2010. PMID: 20150633

9

Apoptotic activity in Libyan breast cancer.

Boder J, Abdalla F, Elfagieh M, Buhmeida A, Collan Y. Boder J, et al. Among authors: collan y. World J Surg Oncol. 2012 Jun 8;10:102. doi: 10.1186/1477-7819-10-102. World J Surg Oncol. 2012. PMID: 22682522 Free PMC article.

10

Prognostic value of bcl-2 expression among women with breast cancer in Libya.

Ermiah E, Buhmeida A, Khaled BR, Abdalla F, Salem N, Pyrhönen S, Collan Y. Ermiah E, et al. Among authors: collan y. Tumour Biol. 2013 Jun;34(3):1569-78. doi: 10.1007/s13277-013-0687-1. Epub 2013 Feb 16. Tumour Biol. 2013. PMID: 23417836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters